Anti-Human CCL2 Recombinant Antibody_天津卡梅德科技发展有限公司

>>

>>

>>

>

Anti-Human CCL2 Recombinant Antibody

Anti-Human CCL2 Recombinant Antibody

产品编号

YR1239

别名

科研级 Carlumab ( 卡芦单抗 ), Anti-CCL2 Recombinant Antibody, Research Grade Carlumab

规格

1mg
5mg

DATASHEET MSDS

立即询价加入询价列表大包装定制

产品介绍

Alias	科研级 Carlumab ( 卡芦单抗 ), Anti-CCL2 Recombinant Antibody, Research Grade Carlumab
Catalog Number	YR1239
Molecular Name	Carlumab
Size	1mg, 5mg
Clonity	Monoclonal
Purity	>95% as determined by SDS-PAGE
Concentration	1mg/ml
Antibody Isotype	IgG1 Kappa
Formulation	PBS, pH7.5
Background	Carlumab (alternate identifier CNTO 888) is a discontinued human recombinant monoclonal antibody (type IgG1 kappa) that targets human CC chemokine ligand 2 (CCL2)/monocyte chemoattractant protein (MCP1). Carlumab was under development for use in the treatment of oncology and immune indications and was studied for application in systemic sclerosis, atherosclerosis, diabetic nephropathy, liver fibrosis and type 2 diabetes.
CAS Number	915404-94-3
Storage Condition	It is recommended to aliquote and store at -20°C for long term storage. Avoid repeated freezing and thawing cycles.
Remarks	This product is for research use only.
Shipping Condition	Shipped on ice packs.
Target	CCL2[Homo sapiens]

推荐产品

400-621-6806
614353794
周一至周五 9:00-18:00
0